The North America Interventional Radiology Products Market is witnessing substantial growth owing to advancements in minimally invasive technology and increasing prevalence of chronic diseases. The market was valued at USD 6,340 Million in 2025 and is projected to reach USD 14,660 Million by 2035, expanding at a CAGR of 7.8% from 2024 to 2035.
The economic impact of tariffs on "North America Interventional Radiology Products Market".
Market Growth Drivers
Rising Prevalence of Chronic Diseases: The growing incidence of cardiovascular diseases, cancer, and other chronic conditions has necessitated the adoption of advanced interventional radiology procedures. Companies such as GE Healthcare are innovating in image-guided therapy systems to support precise and effective interventions. These technological advancements facilitate earlier detection and minimally invasive treatments, which reduce complications and improve patient outcomes, driving higher demand for interventional radiology products in North America.
Increasing Adoption of Minimally Invasive Procedures: The shift towards minimally invasive treatments, due to their shorter recovery times and reduced hospital stays, is significantly propelling market growth. Medtronic, for example, has focused on developing next-generation catheters and guidewires that simplify complex procedures while increasing safety and efficacy. These solutions are increasingly favored by healthcare providers as they enable cost-effective interventions with improved patient satisfaction.
Market Trends
Integration of Artificial Intelligence (AI) and Digital Health: Leading companies, such as Siemens Healthineers, are increasingly integrating AI-based tools in interventional radiology suites, enabling clinicians to gain predictive insights and real-time support during procedures. AI-driven diagnostic imaging and robotic-assisted interventions are rapidly transforming procedural accuracy and workflow efficiency in North American hospitals.
Expansion of Product Portfolios through Strategic Collaborations: Major industry players like Boston Scientific are engaging in partnerships and acquisitions to expand their interventional radiology portfolios. For instance, collaborations between device manufacturers and software developers are producing comprehensive solutions—ranging from advanced stent technologies to real-time imaging software—which enhance interventional outcome and broaden the scope of radiology practices.
Market Opportunities
Growth Potential in Outpatient and Ambulatory Settings: There is strong opportunity for interventional radiology products in outpatient and ambulatory care centers across North America, driven by a shift from inpatient to outpatient procedures. Companies like Philips are developing compact, mobile imaging systems catering to these settings, enabling efficient care delivery and expanding patient access.
Emergence of Personalized Medicine: The growing focus on personalized and precision medicine offers new market opportunities for tailored interventional radiology products, especially in oncology and vascular interventions. This shift enables innovative companies to develop targeted devices and imaging solutions for specific patient populations, fueling future market expansion.
North America Interventional Radiology Products Market Revenue (USD Million), 2020-2035
The revenue chart depicts a strong growth trajectory for the North America Interventional Radiology Products Market between 2020 and 2035. Starting from USD 3,950 Million in 2020, the market has demonstrated steady growth driven by increased demand for minimally invasive procedures and technological advancements. By 2025, revenue rises to USD 6,340 Million, followed by sustained growth at a CAGR of 7.8%, culminating in USD 14,660 Million by 2035. The upward revenue trend highlights the region's robust investment in healthcare infrastructure, expanding geriatric population, and increased utilization of advanced radiological instruments and consumables.
North America Interventional Radiology Products Market by Region, 2025 (%)
The pie chart for market share by region in 2025 illustrates the dominant role of the United States in the North American interventional radiology products market, accounting for 78% share, driven by advanced healthcare infrastructure and high procedure volumes. Canada follows with a 15% share, supported by rising adoption of minimally invasive technology and government health initiatives. Mexico holds a 5% market share, reflecting its emerging healthcare sector. Other regions, including Puerto Rico and others, comprise the remaining 2%. These proportions reflect the economic strength, healthcare capacity, and technology adoption variations across North America.
Recent Developments
In April 2024, GE HealthCare announced the launch of its new AI-powered CT Fluoroscopy Suite in the United States, designed to offer enhanced workflow efficiency and lower radiation exposure for interventional radiology procedures. This development signifies GE’s ongoing commitment to leveraging AI for superior imaging performance and procedural safety.
In March 2024, Boston Scientific entered into a strategic partnership with Viz.ai to deploy advanced artificial intelligence algorithms for stroke detection and neurovascular interventions. The partnership aims to accelerate time-to-treatment and optimize clinical outcomes through seamless integration of AI with Boston Scientific’s interventional products.
In February 2024, Siemens Healthineers expanded its interventional radiology portfolio by acquiring a majority stake in Intact Vascular, a leading developer of minimally invasive peripheral vascular devices. This acquisition is expected to strengthen Siemens’ leadership and product offerings within the peripheral arterial disease intervention segment across North America.
Press Releases